Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
3(20%)
Results Posted
17%(1 trials)
Terminated
1(7%)

Phase Distribution

Ph not_applicable
4
27%
Ph phase_4
5
33%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Phase 4Post-market surveillance
5(55.6%)
N/ANon-phased studies
4(44.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

3

trials recruiting

Total Trials

15

all time

Status Distribution
Active(5)
Completed(6)
Terminated(2)
Other(2)

Detailed Status

Completed6
Recruiting2
unknown2
Not yet recruiting1
Enrolling by invitation1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
3
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 45 (55.6%)
N/A4 (44.4%)

Trials by Status

not_yet_recruiting17%
enrolling_by_invitation17%
active_not_recruiting17%
terminated17%
recruiting213%
unknown213%
completed640%
withdrawn17%

Recent Activity

3 active trials
Showing 5 of 15
not_yet_recruiting

Immun4Cure Cohort of Autoimmune Diseases

NCT07515638
active_not_recruiting

Assessment of Paclitaxel-Induced Neuropathy

NCT01953159
completed

Visual Outcomes and Patient Satisfaction With Bilateral PanOptix Verses Bilateral Synergy

NCT06041139
terminatednot_applicable

Evaluation of the Impact of Therapeutic Education Workshops for COPD Patients in the North-West Val d'Oise Area

NCT06298487
withdrawnnot_applicable

Identification of Post-Traumatic Stress Disorder in Adult Patients With Substance Use Disorders

NCT06432400
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT07515638

Immun4Cure Cohort of Autoimmune Diseases

Not Yet Recruiting
NCT01953159

Assessment of Paclitaxel-Induced Neuropathy

Active Not Recruiting
NCT06041139

Visual Outcomes and Patient Satisfaction With Bilateral PanOptix Verses Bilateral Synergy

Completed
NCT06298487Not Applicable

Evaluation of the Impact of Therapeutic Education Workshops for COPD Patients in the North-West Val d'Oise Area

Terminated
NCT06432400Not Applicable

Identification of Post-Traumatic Stress Disorder in Adult Patients With Substance Use Disorders

Withdrawn
NCT04987723Not Applicable

A Mechanistic Exploratory Study of AF-induced Cardiac Dysfunction and Symptoms

Completed
NCT04083612Phase 4

Therapeutic Drug Monitoring of Ixekizumab in Psoriasis Patients

Completed
NCT04080661Phase 4

Therapeutic Drug Monitoring of Secukinumab in Psoriasis Patients.

Completed
NCT04080635Not Applicable

Therapeutic Drug Monitoring of Brodalumab in Psoriasis Patients (BIOLOPTIM-BRO)

Recruiting
NCT04080648Phase 4

Therapeutic Drug Monitoring of Guselkumab in Psoriasis Patients

Completed
NCT06083155

The NetherLands Registry of Invasive Coronary Vasomotor Function Testing (NL-CFT)

Enrolling By Invitation
NCT05685940Phase 4

Therapeutic Drug Monitoring of Risankizumab in Psoriasis Patients (BIOLOPTIM-RIS)

Recruiting
NCT05683015Phase 4

Therapeutic Drug Monitoring of Tildrakizumab in Psoriasis Patients

Unknown
NCT03672422

Pediatric Longitudinal Cohort Study of Chronic Pancreatitis

Completed
NCT04068090

Taxane Induced Peripheral Neuropathy in Chinese Patients With Breast Cancer

Unknown

All 15 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
15